Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
Clinical trial NCT01581593 · COMPLETED
Trial details
- NCT number
- NCT01581593
- Sponsor
- Kedrion S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-12
- Primary completion
- 2014-08-27
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.